Eagle Pharmaceuticals focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company was founded in 2007 and is based in Woodcliff Lake, New Jersey.
EGRX Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for EGRX, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Eagle Pharmaceuticals Inc ranked in the 66th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 135.5%. The most interesting components of our discounted cash flow analysis for Eagle Pharmaceuticals Inc ended up being:
In the past 4.99 years, Eagle Pharmaceuticals Inc has a compound free cash flow growth rate of 0.39%; that's better than 77.61% of cash flow producing equities in the Healthcare sector, where it is classified.
Eagle Pharmaceuticals Inc's effective tax rate, as measured by taxes paid relative to net income, is at 31 -- greater than 90.94% of US stocks with positive free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Eagle Pharmaceuticals Inc? See MCK, HUM, FTLF, ENDP, and ABBV.
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two upcoming investor conferences as follows: Conference: Jefferies Virtual Healthcare Conference Date: Thursday, June 4, 2020 Time: 1:00 p.m. ET Webcast: http://wsw.com/webcast/jeff126/egrx/ Conference: William Blair Virtual 40th Annual Growth Stock Conference Date: T
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) announced today that, due to public health and safety concerns related to the ongoing COVID-19 global pandemic, recommendations and orders from federal, state and local authorities, and to support the health and well-being of its stockholders, employees and others, Eagle is changing its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) to a virtual-only format that will be held via live audio we
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will host a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference as follows: Date: Tuesday, May 19, 2020 Time: 3:05 p.m. Eastern Time Webcast: https://www.veracast.com/webcasts/rbc/healthcare2020/01112239705.cfm The presentation will be webcast live a